3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine
C18H15F3N8O2S — CID 166717272
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine
3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine (PubChem CID 166717272) has the molecular formula C18H15F3N8O2S and a molecular weight of 464.43 g/mol. Its IUPAC name is 3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine.
Molecular Properties
| Compound Name | 3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine |
|---|---|
| PubChem CID | 166717272 |
| Molecular Formula | C18H15F3N8O2S |
| Molecular Weight | 464.43 g/mol |
| Exact Mass | 464.10 |
| IUPAC Name | 3-ethylsulfonyl-2-[4-methyl-5-[4-(trifluoromethyl)-2-pyridinyl]-1,2,4-triazol-3-yl]-5-(1,2,4-triazol-1-yl)pyridine |
| SMILES | CCS(=O)(=O)c1cc(-n2cncn2)cnc1-c1nnc(-c2cc(C(F)(F)F)ccn2)n1C |
| InChI | InChI=1S/C18H15F3N8O2S/c1-3-32(30,31)14-7-12(29-10-22-9-25-29)8-24-15(14)17-27-26-16(28(17)2)13-6-11(4-5-23-13)18(19,20)21/h4-10H,3H2,1-2H3 |
| InChIKey | SVWFQNAONFIXEY-UHFFFAOYSA-N |
| XLogP | 2.33 |
| TPSA | 121.34 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 464.43 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166717272 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.